Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
18 June 2010
IN THIS ISSUE
Pfizer’s new research unit
Increasing EU public trust
Pharmaceuticals in the water
Last chance to win
 
Pfizer establishes new research unit for rare diseases
Pfizer has created a new research unit that will focus on rare diseases. The unit will pursue treatments in all therapeutic areas and the company has also said it will collaborate with patient advocacy groups. More...
 
Europe builds trust in risk/benefit studies
A new form of study for assessing the benefits and risks of medicines has been launched in the EU with the hope of increasing public trust in study findings. More...
 
Is an Oxycodone spill possible?
The ongoing oil spill has brought pollution to the center of the public consciousness again, but although the environmental effects of the petroleum industry’s operations have been the subject of public scrutiny for years, we should also remember that the pharma industry can sometimes release pollutants into our waterways, too. More...
 
Your last chance to win an iPod Touch
What are we getting right and what can we improve upon? Give your opinion of Pharmaceutical Technology Europe by taking part in a short survey and be in with the chance of winning an iPod Touch! More...
 
Pharma urged to fight drug resistance
The world is rapidly losing its ability to treat malaria, HIV and tuberculosis, as well as more common diseases such as dysentery and respiratory infections because of drug resistance, according to a report from the Center for Global Development (CGD). More...
 
Clinical information-sharing consortium formed
A coalition comprising numerous stakeholders has been formed that will share information among companies and researchers on a global basis regarding clinical trials for treatments for neurodegenerative diseases. More...

Latest blog posts
Eli Lilly CEO addresses shortfall in scientific innovation
Requirements for extractables & leachables can be confusing, to say the least
WHO done wrong?
More blog posts

Latest articles
Tabletting: the issues facing today's manufacturers
Assessing environmental risk of pharmaceuticals
Data sharing more efficient with purpose-built LIMS
More latest articles

July events
AgriGenomics World Congress 2010 (8–9 July | Belgium)
37th Annual Meeting & Exposition of the Controlled Release Society (10–14 July | USA)
2nd Annual Conference In Vitro Diagnostics (12–13 July | UK)
More events

Podcast
Vetter
The North American market is critical to Vetter’s strategic global growth as nearly half of its client base is already located here. In order to maximize on this opportunity, Vetter has decided to create a facility, its first outside of Germany, at the Illinois Science + Technology Park in suburban Chicago.

Read more...


Survey
Which anti counterfeiting solution is your company currently using?
  RFID 10%
  Barcoding 26%
  On-dose technologies 7%
  Tamper-evident packaging 19%
  Other 12%
  None 26%

This week we would like to know...

Should the FDA have mandatory recall authority and the power to halt drug production?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom